GlassScriptPhysician profile
Danielle Catudio
NPI 1780059881
$751.55
in general payments reported to CMS, 2019-2025
14 companies · $194 in 2025
The $194 reported for 2025 was more than what a typical Pediatrics (Nurse Practitioner) provider received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $51.74 · 2022: $44.88 · 2023: $262 · 2024: $200 · 2025: $194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $655.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $654.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $147.92 | 2021-2024 | Auvi-Q |
| Merck Sharp & Dohme LLC | $120.68 | 2023-2025 | Gardasil 9, Vaxneuvance, M-M-R II |
| Glaxosmithkline, LLC. | $102.42 | 2021-2025 | Bexsero, Rotarix, Pediarix |
| Alk-Abello, INC | $82.26 | 2023-2025 | Grastek, Odactra, Ragwitek |
| Sanofi-Aventis U.S. LLC | $52.90 | 2024-2025 | |
| Sanofi Pasteur INC. | $48.09 | 2023-2024 | |
| Medline Industries LP | $38.25 | 2023 | Medline Industries, INC., Remedy Skin Protectant |
| Cranial Technologies, INC | $33.64 | 2025 | Doc Band |
| Genzyme Corporation | $24.84 | 2023 | |
| Phadia US INC. | $21.31 | 2025 | Immunocap |
| Pfizer INC. | $20.93 | 2023 | |
| Corium, LLC | $20.07 | 2024 | Azstarys |
| Itamar Medical INC | $19.14 | 2024 | Watchpatone |
| Astrazeneca Pharmaceuticals LP | $19.10 | 2023 | Flumist Quadrivalent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Catudio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.